Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

TARDIS: The Improved Method of Detecting Breast Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer History

What Role do Biobanks Play in Cancer Research?

What is Cancer of Unknown Primary?

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Management

What is Merkel Cell Carcinoma?

What Causes Cancer?

Cancer Prognosis

Transforming Cancer Care through Genomic Testing

See more featured articles »

Hypoxia Markers and Their Importance

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Metastatic Migration in Cancer may be Influenced by Metabolism

Microfluidic cancer treatment screen combined with flow cytometry

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Insights into Oncofertility

Assay for Monitoring and Treating Malignant Brain Tumors

CDK9 and Cancer

Myc Mutations and Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

British Pioneers in Cancer Biology

Cancer Symptoms

What is Immunochemotherapy?

Cancer Pathophysiology

Using Biomarkers to Detect Cancer

Why are Cancer Cell Lines Useful?

Cancer Pain

What is Cancer?

What is the Tumor Microenvironment?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Overview of Cell Viability and Cytotoxicity

Investigating the Molecular Mechanisms of Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

What is Tumorigenesis?

Is Cancer a Metabolic Disorder?

The Cancer Cell Surface Proteome as a Therapeutic Target

Cancer Epidemiology

Acidosis and Tumor Progression

The Biochemistry of Breast Cancer Screening

The Effects of Cancer on Family Life

Hot vs Cold: the differences between tumor types

Living with Cancer Pain

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Insight into Cancer Vaccines

Cancer Screening Considerations: Balancing the Benefits and Risks

Secondary Lung Cancer

Cancer Research

Cutaneous Manifestations of Internal Malignancy

Cancer Glossary

Targeted Cancer Therapies

Secondary Brain Cancer

Cancer Pain Management

Cancer Diagnosis

Cancer Classification

Pediatric Cancer

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Prevention: Lowering your Risk

Caring for a Loved One with Cancer

Latest Cancer News and Research

Mitochondrial checkpoint enables dendritic cells to activate T lymphocytes against viruses, tumors

A study led by researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has identified a mitochondrial "checkpoint" that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors.

22 May 2026

New biomarker predicts therapy response for hard-to-treat childhood cancers

A study by researchers at the University of Birmingham has identified a new biomarker for response to a specific cancer therapy, treating children with Ewing Sarcoma and other tumor types.

22 May 2026

Scientists map genetic variants behind prostate cancer therapy failure

Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research Fellow at Zhejiang Provincial People's Hospital, published a review entitled "Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer".

22 May 2026

Targeting lipid enzymes triggers starvation states in aggressive tumor cells

While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for the metabolite.

22 May 2026

Scientists urge advocacy to protect vital global vaccine research

Scientists and physicians should advocate to protect the vaccine research infrastructure that has saved an estimated 154 million lives over the past 50 years, according to a new commentary by researchers at Weill Cornell Medicine and the University of Washington.

22 May 2026

Second-career nursing candidates help solve national staffing shortages

While the usual conversation about our national nursing shortage focuses on how to recruit young people, there is another potential pipeline: people in their 40s and 50s—often pursuing a second career—who are also, in many ways, exactly the nurses that NYU Langone Health needs.

22 May 2026

Mental disorders surpass other conditions as leading global cause of disability

Nearly 1.2 billion people worldwide are living with a mental disorder, nearly double the number recorded in 1990.

22 May 2026

New study reveals nitric oxide’s widespread impact on genetics

Genes undergo extensive editing through a process called alternative splicing, which greatly increases the size of the functional genome, the working portion of our DNA that helps make each person unique. Put simply, a single gene can be edited in different ways to produce multiple sets of instructions.

22 May 2026

Explainable AI could make breast cancer drug predictions safer and clearer

AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast cancer treatment. The review proposes an interpretability-driven framework that links multi-omics data, mechanistic validation, and clinical translation to make AI predictions more transparent and clinically useful.

22 May 2026

Research show worsening health trends for post-1946 generations

Younger generations appear to be experiencing poorer health earlier in life than previous generations, according to a review of studies comparing national birth cohort datasets involving tens of thousands of people across the UK born since 1946.

22 May 2026

New discovery maps how mutant colorectal tumors adapt to KRAS inhibitors

A new preclinical study led by researchers at The University of Texas MD Anderson Cancer Center and Weill Cornell Medicine has uncovered genetic and cell-state adaptive mechanisms that drive resistance to KRAS inhibitors in patients with KRAS-mutant colorectal cancer.

22 May 2026

Excess EXO1 protein may drive cancer DNA damage and treatment response

When it comes to cancer, tumor suppressor genes are usually thought of as the "good guys." These genes make proteins that protect and repair DNA in cells.

21 May 2026

AI-created miniproteins show promise for targeting hard-to-treat diseases

G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a living cell. They communicate with nearly every physiological process in our bodies - from the ability to see and smell, to sensing of adrenaline, insulin, nutrients and medicines.

21 May 2026

Scientists capture immune cells attacking live melanoma cells in real time

Scientists at the Garvan Institute of Medical Research have captured, for the first time, 'housekeeping' immune cells actively attacking and engulfing live melanoma cells – a discovery that could change the way we approach treatment for one of Australia's most common and deadly cancers.

21 May 2026

Oral drug improves platelet recovery during chemotherapy in gastrointestinal cancer patients

An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet recovery and helped patients with gastrointestinal cancers maintain platelet counts needed to continue chemotherapy as scheduled, according to results from a phase 2 clinical trial led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and Mass General Hospital.

21 May 2026

Experimental virus therapy targets resistant high-grade neuroendocrine tumors

A phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment.

21 May 2026

Artificial intelligence-based tool could improve multiple myeloma treatment decisions

An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.

21 May 2026

Specific gene fusion patterns tied to solitary fibrous tumor outcomes

Specific genetic fusion patterns in solitary fibrous tumors may help identify which patients face a higher risk of metastasis, recurrence and more aggressive disease behavior, according to new research that could improve how physicians assess and eventually treat this rare cancer.

21 May 2026

New eye drop formulation shows promise for dry eye disease

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease.

21 May 2026

Vitamin B12 analog targets deadly brain cancer cells

A new research paper was published in Volume 13 of Oncoscience on April 2, 2026, titled "Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide."

21 May 2026